Bartova, Lucie http://orcid.org/0000-0002-1769-8025
Dold, Markus http://orcid.org/0000-0001-8914-2192
Volz, Hans-Peter http://orcid.org/0000-0001-5438-8918
Seifritz, Erich http://orcid.org/0000-0002-7311-4426
Möller, Hans-Jürgen
Kasper, Siegfried http://orcid.org/0000-0001-8278-191X
Article History
Received: 2 December 2021
Accepted: 1 February 2022
First Online: 9 March 2022
Declarations
:
: <i>LB</i> has received travel grants and consultant/speaker honoraria from AOP Orphan, Medizin Medien Austria, Vertretungsnetz, Schwabe Austria, Janssen and Angelini. <i>MD</i> has received travel grants and consultant/speaker honoraria from Janssen-Cilag. Within the last 3 years, <i>H-PV</i> has served as a consultant or on advisory boards for Astra/Zeneca, Eli Lilly, Lundbeck, Pfizer, Schwabe, Janssen, Otsuka, Angelini, and Sage and has served on speakers’ bureaus for Astra/Zeneca, Eli Lilly, Lundbeck, Schwabe, Janssen, Bayer, Recordati and neuraxpharm. <i>ES</i> received in the last 3 years honoraria and grants for advice and educational lectures from Lundbeck Switzerland, Schwabe Switzerland and Germany, Janssen Switzerland, Otsuka Switzerland, Mepha Pharma Switzerland, Otsuka Pharma Switzerland, Ricordati Switzerland and Sunovion Pharma UK and Angelini. <i>H-JM</i> has received grant/research support, consulting fees and honoraria within the last years from AstraZeneca, Lundbeck, Otsuka, and Schwabe. <i>SK</i> has received grant/research support from Lundbeck; he has served as a consultant or on advisory boards for Angelini, Biogen, Esai, Janssen, IQVIA, Lundbeck, Mylan, Recordati, Sage and Schwabe; and he has served on speakers bureaus for Aspen Farmaceutica S.A., Angelini, Biogen, Janssen, Lundbeck, Neuraxpharma, Recordati, Sage, Sanofi, Schwabe, Servier and Sun Pharma.
: Our research complies with internationally accepted standards for research practice and reporting. The present investigation was carried out in accordance with the latest version of the Declaration of Helsinki.
: Not applicable.
: Not applicable.